ARQT — ARCUTIS BIOTHERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 283 家机构在其最新 13F 申报中持有 ARQT(ARCUTIS BIOTHERAPEUTICS INC),合计申报市值 $3.55B,对应 135.38M 股。按股数计算较上季度减持 1.7%(-2.17M 股),申报市值环比上升 9.7%。持仓集中度较高:前五大持有人占申报市值的 35.3%,前十大的集中度为 51.2%。
与上一季度相比,44 家新建仓位、93 家加仓、105 家减仓、42 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
ARCUTIS BIOTHERAPEUTICS INC(ARQT)的主要机构持有人包括 BlackRock Inc、MONTANOVA CAPITAL, LLC、Frazier Life Sciences Management, L.P.,按 13F 申报市值在本页 521 家持有人中排名居前。
ARQT 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 211 | 78.51M | $2.09B | +29.0% |
| Q2 2026 | 283 | 135.38M | $3.55B | -1.5% |
| Q1 2026 | 280 | 137.69M | $3.23B | +1.3% |
| Q4 2025 | 292 | 135.06M | $3.89B | +0.6% |
| Q3 2025 | 245 | 129.20M | $2.43B | -1.3% |
| Q2 2025 | 234 | 131.78M | $1.84B | +4.0% |
| Q1 2025 | 243 | 129.25M | $2.01B | -8.3% |
| Q4 2024 | 207 | 135.78M | $1.99B | +4.7% |
表内 8 个季度中,机构持股合计减少 42%(Q4 2024 → Q3 2026);单季变动最大的是 Q1 2025(-8.3%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 19.17M | $506.69M | 0.01% | 增持 | |
| 7.72M | $204.00M | 0.01% | 增持 | |
| 5.53M | $146.24M | 0.06% | 增持 | |
| 5.30M | $139.99M | 0.01% | 增持 | |
| 4.99M | $131.99M | 0.00% | 持有 | |
| 3.82M | $100.90M | 0.01% | 增持 | |
| 2.97M | $78.53M | 0.00% | 持有 | |
| 1.98M | $67.36M | 0.01% | 增持 | |
| 1.98M | $52.22M | 0.02% | 增持 | |
| 1.35M | $35.75M | 0.30% | 增持 | |
| 1.20M | $31.85M | 0.04% | 增持 | |
| 1.17M | $30.81M | 0.04% | 增持 | |
| 1.01M | $26.65M | 10.86% | 减持 | |
| 1.00M | $26.63M | 0.12% | 增持 | |
| 958.84K | $25.34M | 0.39% | 减持 | |
| 873.55K | $23.09M | 0.04% | 减持 | |
| 865.86K | $22.88M | 0.38% | 新进 | |
| 814.48K | $21.53M | 0.01% | 持有 | |
| 813.89K | $21.51M | 0.02% | 持有 | |
| 803.52K | $21.24M | 0.01% | 增持 | |
| 776.83K | $20.53M | 0.08% | 增持 | |
| 769.78K | $20.35M | 0.01% | 减持 | |
| 774.31K | $20.33M | 0.05% | 新进 | |
| 709.62K | $18.76M | 0.09% | 增持 | |
| 597.12K | $15.78M | 1.27% | 持有 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 12.44M | $326.10M | 5.96% | 增持 | |
| 10.55M | $276.50M | 0.01% | 增持 | |
| 9.87M | $258.91M | 5.64% | 持有 | |
| 8.27M | $216.88M | 2.00% | 持有 | |
| 6.61M | $173.23M | 0.50% | 增持 | |
| 4.99M | $130.81M | 0.00% | 增持 | |
| 4.45M | $116.71M | 0.01% | 增持 | |
| 4.22M | $110.62M | 0.07% | 减持 | |
| 3.95M | $103.56M | 0.05% | 增持 | |
| 3.95M | $103.56M | 0.15% | 增持 | |
| 3.33M | $87.39M | 0.04% | 持有 | |
| 2.99M | $78.33M | 0.01% | 增持 | |
| 2.98M | $78.21M | 0.00% | 新进 | |
| 2.98M | $78.21M | 0.00% | 减持 | |
| 2.43M | $63.69M | 0.00% | 增持 | |
| 2.04M | $53.54M | 1.08% | 新进 | |
| 1.93M | $50.63M | 0.01% | 减持 | |
| 1.93M | $50.47M | 0.02% | 增持 | |
| 1.67M | $43.74M | 0.01% | 增持 | |
| 1.41M | $36.99M | 0.01% | 新进 | |
| 1.37M | $36.00M | 0.74% | 增持 | |
| 1.31M | $34.43M | 0.35% | 减持 | |
| 1.29M | $33.77M | 0.26% | 增持 | |
| 1.27M | $33.18M | 10.78% | 减持 | |
| 1.25M | $32.86M | 0.08% | 增持 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 12.33M | $290.42M | 7.42% | 增持 | |
| 9.87M | $232.64M | 5.99% | 持有 | |
| 9.20M | $216.76M | 0.01% | 增持 | |
| 8.27M | $194.88M | 2.08% | 持有 | |
| 6.30M | $148.34M | 0.01% | 增持 | |
| 5.67M | $133.51M | 0.59% | 增持 | |
| 4.98M | $117.35M | 0.08% | 减持 | |
| 4.87M | $114.77M | 0.00% | 新进 | |
| 4.30M | $101.40M | 1.22% | 减持 | |
| 4.22M | $99.40M | 0.01% | 减持 | |
| 3.33M | $78.44M | 0.04% | 增持 | |
| 3.05M | $71.76M | 0.00% | 增持 | |
| 2.50M | $58.81M | 0.04% | 减持 | |
| 2.50M | $58.81M | 0.11% | 减持 | |
| 2.43M | $57.29M | 0.09% | 增持 | |
| 2.30M | $54.14M | 0.01% | 增持 | |
| 2.23M | $52.45M | 0.39% | 减持 | |
| 2.22M | $52.33M | 0.00% | 增持 | |
| 1.95M | $46.05M | 0.00% | 新进 | |
| 1.85M | $43.68M | 0.02% | 增持 | |
| 1.60M | $37.77M | 0.01% | 增持 | |
| 1.46M | $34.47M | 0.02% | 持有 | |
| 1.37M | $32.18M | 0.95% | 增持 | |
| 1.36M | $31.94M | 11.42% | 减持 | |
| 1.24M | $29.32M | 0.06% | 减持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 11.96M | $347.43M | 7.12% | 增持 | |
| 9.87M | $286.76M | 7.70% | 持有 | |
| 9.10M | $264.25M | 0.01% | 增持 | |
| 8.27M | $240.21M | 2.89% | 减持 | |
| 7.25M | $210.65M | 0.00% | 增持 | |
| 6.76M | $196.25M | 0.12% | 减持 | |
| 5.56M | $161.35M | 0.75% | 增持 | |
| 5.49M | $159.38M | 0.01% | 增持 | |
| 4.45M | $129.34M | 1.36% | 增持 | |
| 4.34M | $126.04M | 0.01% | 增持 | |
| 3.24M | $94.19M | 0.05% | 增持 | |
| 2.75M | $79.97M | 0.01% | 增持 | |
| 2.68M | $77.92M | 0.05% | 增持 | |
| 2.68M | $77.92M | 0.15% | 增持 | |
| 2.56M | $74.41M | 0.51% | 增持 | |
| 1.90M | $55.25M | 0.10% | 减持 | |
| 1.90M | $55.18M | 0.02% | 减持 | |
| 1.83M | $53.15M | 0.02% | 减持 | |
| 1.67M | $48.60M | 0.00% | 增持 | |
| 1.58M | $45.78M | 0.02% | 减持 | |
| 1.47M | $42.61M | 0.02% | 减持 | |
| 1.38M | $40.14M | 0.01% | 增持 | |
| 1.37M | $39.69M | 15.34% | 减持 | |
| 1.17M | $33.87M | 0.00% | 增持 | |
| 1.01M | $29.47M | 0.01% | 增持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 12.25M | $230.99M | 0.13% | 增持 | |
| 10.75M | $202.63M | 2.31% | 持有 | |
| 10.48M | $197.51M | 5.11% | 减持 | |
| 9.87M | $186.13M | 5.58% | 持有 | |
| 8.57M | $161.62M | 0.00% | 持有 | |
| 7.15M | $134.70M | 0.00% | 增持 | |
| 5.30M | $99.88M | 0.52% | 增持 | |
| 4.64M | $87.49M | 0.00% | 增持 | |
| 4.43M | $83.49M | 0.85% | 增持 | |
| 4.28M | $80.61M | 0.01% | 减持 | |
| 2.95M | $55.58M | 0.03% | 持有 | |
| 2.61M | $49.14M | 0.00% | 增持 | |
| 2.40M | $45.18M | 0.02% | 增持 | |
| 2.31M | $43.56M | 0.01% | 减持 | |
| 2.12M | $39.97M | 23.11% | 持有 | |
| 2.12M | $39.94M | 0.08% | 减持 | |
| 2.12M | $39.94M | 0.03% | 减持 | |
| 2.02M | $38.16M | 0.47% | 增持 | |
| 1.99M | $37.57M | 0.06% | 持有 | |
| 1.80M | $34.02M | 0.01% | 减持 | |
| 1.66M | $31.34M | 0.02% | 减持 | |
| 1.37M | $25.83M | 0.01% | 增持 | |
| 1.17M | $22.09M | 0.20% | 减持 | |
| 1.10M | $20.68M | 0.15% | 增持 | |
| 999.43K | $18.84M | 0.00% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 11.54M | $161.73M | 4.99% | 增持 | |
| 11.11M | $155.75M | 0.09% | 减持 | |
| 10.75M | $150.71M | 2.30% | 减持 | |
| 9.87M | $138.44M | 5.54% | 增持 | |
| 8.53M | $119.63M | 0.00% | 减持 | |
| 7.05M | $98.83M | 0.00% | 增持 | |
| 5.01M | $70.19M | 0.37% | 减持 | |
| 4.53M | $63.47M | 0.00% | 增持 | |
| 4.31M | $60.49M | 0.00% | 增持 | |
| 4.16M | $58.26M | 0.62% | 增持 | |
| 2.94M | $41.19M | 0.03% | 增持 | |
| 2.73M | $38.31M | 0.01% | 减持 | |
| 2.58M | $36.21M | 0.00% | 增持 | |
| 2.26M | $31.76M | 0.02% | 增持 | |
| 2.16M | $30.33M | 0.07% | 增持 | |
| 2.16M | $30.33M | 0.02% | 增持 | |
| 2.12M | $29.73M | 18.43% | 持有 | |
| 2.00M | $28.06M | 0.05% | 增持 | |
| 1.89M | $26.50M | 0.01% | 增持 | |
| 1.72M | $24.17M | 0.01% | 增持 | |
| 1.49M | $20.83M | 0.10% | 增持 | |
| 1.38M | $19.33M | 0.17% | 减持 | |
| 1.20M | $16.86M | 0.00% | 增持 | |
| 1.09M | $15.23M | 0.12% | 减持 | |
| 1.00M | $14.02M | 1.04% | 减持 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.98M 股 · $78.21M
- ORBIMED ADVISORS LLC 2.04M 股 · $53.54M
- Jupiter Topco LLC 1.41M 股 · $36.99M
- Jones Hill Capital LP 1.09M 股 · $28.57M
- Sixth Street Partners Management Company, L.P. 1.05M 股 · $27.56M
- Longaeva Partners L.P. 344.80K 股 · $9.04M
- Balyasny Asset Management 243.12K 股 · $6.37M
- PFM Health Sciences, LP 242.07K 股 · $6.35M
- Holocene Advisors, LP 163.73K 股 · $4.29M
- TUDOR INVESTMENT CORP ET AL 131.91K 股 · $3.46M
- JACOBS LEVY EQUITY MANAGEMENT, INC 86.03K 股 · $2.26M
- Y-Intercept (Hong Kong) Ltd 75.57K 股 · $1.98M
完全清仓(较上季)
- STATE STREET CORP 卖出 6.30M 股 · $148.34M
- Janus Henderson Group 卖出 1.85M 股 · $43.68M
- MPM BioImpact LLC 卖出 733.97K 股 · $17.29M
- M&G Plc 卖出 469.08K 股 · $11.26M
- ZEVENBERGEN CAPITAL INVESTMENTS LLC 卖出 357.49K 股 · $8.42M
- Penn Capital Management Company, LLC 卖出 333.13K 股 · $7.86M
- Hillsdale Investment Management Inc. 卖出 188.22K 股 · $4.43M
- NORDEA INVESTMENT MANAGEMENT AB 卖出 192.92K 股 · $4.41M
- Jackson Creek Investment Advisors LLC 卖出 68.65K 股 · $1.62M
- Engineers Gate Manager LP 卖出 65.98K 股 · $1.55M
- Invst, LLC 卖出 35.20K 股 · $829.43K
- Campbell & CO Investment Adviser LLC 卖出 31.54K 股 · $743.18K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 19.17M | 10.55M | 9.20M | 9.10M | 8.57M | 8.53M | 8.89M | 9.15M | 9.03M | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 7.72M | — | 6.30M | 5.49M | 4.64M | 4.53M | 4.47M | 4.95M | 5.64M | 5.13M | 8.78M | 1.53M | 4.36M | — | — | — | — | — | — | — |
| UBS Group AG | 5.53M | 3.33M | 3.33M | 3.24M | 2.95M | 2.94M | 2.92M | 2.79M | 220.19K | 309.57K | 490.68K | 2.10K | 64.14K | 139.75K | 88.78K | 193.31K | 23.57K | 16.72K | 54.30K | 54.66K |
| Morgan Stanley | 5.30M | 4.45M | 4.22M | 4.34M | 4.28M | 4.31M | 3.84M | 4.24M | 3.78M | 3.97M | 4.01M | 6.08M | 222.04K | 485.98K | 337.65K | 198.06K | 124.93K | 108.17K | 97.45K | 53.02K |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.99M | 4.99M | 4.87M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.82M | 2.43M | 1.95M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 2.97M | 2.98M | 3.05M | 2.75M | 2.61M | 2.58M | 2.55M | 2.47M | 2.47M | 2.42M | 1.97M | 1.74M | 1.04M | 937.45K | 808.37K | 779.14K | 734.24K | 568.67K | 509.38K | 489.34K |
| Franklin Resources | 1.98M | 1.93M | 2.30M | 1.90M | 2.31M | 2.73M | 2.76M | 3.31M | 4.25M | 4.44M | 4.64M | 4.66M | 1.29M | 1.65M | 1.59M | 797.74K | 799.00K | 793.90K | 659.84K | 615.75K |
| AMERICAN CENTURY COMPANIES INC | 1.98M | 1.93M | 1.46M | 1.47M | 1.66M | 1.72M | 1.65M | 1.63M | 1.46M | 1.23M | 1.04M | 911.80K | 510.09K | — | — | — | — | — | — | — |
| GW&K Investment Management, LLC | 1.35M | 1.29M | 988.39K | 1.01M | 1.17M | 1.38M | 1.51M | 1.54M | 1.59M | 1.67M | 1.72M | 1.64M | 2.07M | — | — | — | — | — | — | — |
| Aberdeen Group plc | 1.20M | 1.10M | 645.07K | 586.40K | 675.03K | 675.03K | 587.54K | 482.07K | 482.07K | 148.87K | 148.87K | 148.87K | — | — | — | — | — | — | — | — |
| FEDERATED HERMES, INC. | 1.17M | 1.12M | 1.08M | 891.77K | 759.57K | 737.37K | 737.55K | 492.92K | 501.83K | 350.11K | 350.11K | 521.47K | 60.00K | — | — | — | — | — | — | — |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.01M | 1.27M | 1.36M | 1.37M | 2.12M | 2.12M | 2.12M | 2.12M | 2.12M | 2.04M | 2.03M | 1.91M | 1.11M | — | — | — | — | — | — | — |
| Candriam S.C.A. | 1.00M | 949.84K | 1.09M | 803.14K | 778.04K | 790.43K | 1.04M | 1.04M | 1.43M | 1.31M | — | — | — | — | — | — | — | — | — | — |
| Perpetual Ltd | 958.84K | 1.11M | 909.55K | 910.63K | 2.02M | 26.52K | 26.52K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Ensign Peak Advisors, Inc | 873.55K | 974.53K | 1.24M | 1.90M | 1.99M | 2.00M | 1.99M | 2.37M | 2.42M | 2.13M | 2.98M | 2.03M | 826.10K | — | — | — | — | — | — | — |
| Simplify Asset Management Inc. | 865.86K | — | — | — | 318.00K | 409.43K | 660.56K | 742.30K | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 814.48K | 815.14K | 771.76K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Manulife Financial | 813.89K | 811.75K | 503.86K | 125.98K | 56.02K | 57.95K | 58.09K | 50.96K | 52.50K | 40.32K | 30.79K | 33.51K | 21.04K | 21.04K | 16.39K | 17.07K | 14.23K | 14.15K | 12.22K | 15.43K |
| Principal Global Investors | 803.52K | 183.66K | 168.83K | — | — | — | — | — | — | 18.55K | 19.12K | 18.42K | 15.08K | 14.94K | 13.38K | 14.36K | 11.71K | 11.09K | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold ARQT?
As of 2026-Q2, 283 institutional funds reported holding ARQT (ARCUTIS BIOTHERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $3.55B.
How many shares of ARQT do institutions own?
13F filers reported 135.38M shares of ARQT, worth $3.55B in aggregate at the end of 2026-Q2.
Is institutional ownership of ARQT rising or falling?
Share counts moved -1.7% versus the prior quarter — distribution.
Who are the top institutional holders of ARQT?
The largest 13F holders are BlackRock Inc, MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of ARCUTIS BIOTHERAPEUTICS INC?
The major shareholders of ARCUTIS BIOTHERAPEUTICS INC (ARQT) by reported 13F value are BlackRock Inc, MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, Vanguard Group, among 521 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.